These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30373672)

  • 1. Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [
    Risacher SL; Farlow MR; Bateman DR; Epperson F; Tallman EF; Richardson R; Murrell JR; Unverzagt FW; Apostolova LG; Bonnin JM; Ghetti B; Saykin AJ
    Acta Neuropathol Commun; 2018 Oct; 6(1):114. PubMed ID: 30373672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.
    Kepe V; Ghetti B; Farlow MR; Bresjanac M; Miller K; Huang SC; Wong KP; Murrell JR; Piccardo P; Epperson F; Repovs G; Smid LM; Petric A; Siddarth P; Liu J; Satyamurthy N; Small GW; Barrio JR
    Brain Pathol; 2010 Mar; 20(2):419-30. PubMed ID: 19725833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gerstmann-Sträussler-Scheinker Disease with F198S Mutation Induces Independent Tau and Prion Protein Pathologies in Bank Voles.
    Bruno R; Pirisinu L; Riccardi G; D'Agostino C; De Cecco E; Legname G; Cardone F; Gambetti P; Nonno R; Agrimi U; Di Bari MA
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease.
    Deters KD; Risacher SL; Yoder KK; Oblak AL; Unverzagt FW; Murrell JR; Epperson F; Tallman EF; Quaid KA; Farlow MR; Saykin AJ; Ghetti B
    Am J Nucl Med Mol Imaging; 2016; 6(1):84-93. PubMed ID: 27069768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Tau filaments in Prion protein amyloidoses.
    Hallinan GI; Hoq MR; Ghosh M; Vago FS; Fernandez A; Garringer HJ; Vidal R; Jiang W; Ghetti B
    Acta Neuropathol; 2021 Aug; 142(2):227-241. PubMed ID: 34128081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of in vivo retention of [
    Freiburghaus T; Pawlik D; Oliveira Hauer K; Ossenkoppele R; Strandberg O; Leuzy A; Rittmo J; Tremblay C; Serrano GE; Pontecorvo MJ; Beach TG; Smith R; Hansson O
    Acta Neuropathol; 2024 Sep; 148(1):44. PubMed ID: 39297933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology.
    Matamoros-Angles A; Gayosso LM; Richaud-Patin Y; di Domenico A; Vergara C; Hervera A; Sousa A; Fernández-Borges N; Consiglio A; Gavín R; López de Maturana R; Ferrer I; López de Munain A; Raya Á; Castilla J; Sánchez-Pernaute R; Del Río JA
    Mol Neurobiol; 2018 Apr; 55(4):3033-3048. PubMed ID: 28466265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family with hereditary cerebellar ataxia finally confirmed as Gerstmann-Straussler-Scheinker syndrome with P102L mutation in PRNP gene.
    Long L; Cai X; Shu Y; Lu Z
    Neurosciences (Riyadh); 2017 Apr; 22(2):138-142. PubMed ID: 28416787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid.
    Ishizawa K; Mitsufuji T; Shioda K; Kobayashi A; Komori T; Nakazato Y; Kitamoto T; Araki N; Yamamoto T; Sasaki A
    Brain Behav; 2018 Oct; 8(10):e01117. PubMed ID: 30240140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the nigrostriatal system in Gerstman-Sträussler-Scheinker disease with the PRNP-P102L mutation.
    Ono N; Suzuyama K; Minagawa H; Uwatoko K; Yoshikawa M; Ide T; Mitsuoka M; Honda K; Hirai T; Otsuka T; Kai K; Honda H; Kitamoto T; Irie H; Yukitake M; Koike H
    J Neurol Sci; 2024 Sep; 464():123166. PubMed ID: 39128159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred).
    Piccardo P; Seiler C; Dlouhy SR; Young K; Farlow MR; Prelli F; Frangione B; Bugiani O; Tagliavini F; Ghetti B
    J Neuropathol Exp Neurol; 1996 Nov; 55(11):1157-63. PubMed ID: 8939199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
    Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
    Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
    J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia.
    Ishizawa K; Komori T; Shimazu T; Yamamoto T; Kitamoto T; Shimazu K; Hirose T
    Acta Neuropathol; 2002 Oct; 104(4):342-50. PubMed ID: 12200619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryo-EM structures of prion protein filaments from Gerstmann-Sträussler-Scheinker disease.
    Hallinan GI; Ozcan KA; Hoq MR; Cracco L; Vago FS; Bharath SR; Li D; Jacobsen M; Doud EH; Mosley AL; Fernandez A; Garringer HJ; Jiang W; Ghetti B; Vidal R
    Acta Neuropathol; 2022 Sep; 144(3):509-520. PubMed ID: 35819518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.
    Piccardo P; Liepnieks JJ; William A; Dlouhy SR; Farlow MR; Young K; Nochlin D; Bird TD; Nixon RR; Ball MJ; DeCarli C; Bugiani O; Tagliavini F; Benson MD; Ghetti B
    Am J Pathol; 2001 Jun; 158(6):2201-7. PubMed ID: 11395398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.